The estimated Net Worth of Bronwen Bastone is at least $2.17 Millón dollars as of 18 June 2024. Ms Bastone owns over 28,780 units of Enfusion stock worth over $1,601,250 and over the last 2 years she sold ENFN stock worth over $568,067.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms Bastone ENFN stock SEC Form 4 insiders trading
Ms has made over 7 trades of the Enfusion stock since 2023, according to the Form 4 filled with the SEC. Most recently she sold 28,780 units of ENFN stock worth $233,981 on 18 June 2024.
The largest trade she's ever made was selling 34,059 units of Enfusion stock on 20 May 2024 worth over $325,263. On average, Ms trades about 3,755 units every 19 days since 2022. As of 18 June 2024 she still owns at least 198,913 units of Enfusion stock.
You can see the complete history of Ms Bastone stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Bronwen Bastone biography
Bronwen Bastone is the Chief People Officer at Enfusion.
What's Ms Bastone's mailing address?
Bronwen's mailing address filed with the SEC is C/O ENFUSION, INC., 125 SOUTH CLARK STREET SUITE 750, CHICAGO, IL, 60603.
Insiders trading at Enfusion
Over the last 3 years, insiders at Enfusion have traded over $144,301,080 worth of Enfusion stock and bought 2,523,188 units worth $42,894,196 . The most active insiders traders include Investment Management, Ltd...., Bradford Eftv Iv, L.P. Bern... y Tarek Lra Ventures, Llc Ham.... On average, Enfusion executives and independent directors trade stock every 22 days with the average trade being worth of $2,488,344. The most recent stock trade was executed by Valeria Gutowski on 18 June 2024, trading 1,258 units of ENFN stock currently worth $10,278.
What does Enfusion's logo look like?
Complete history of Ms Bastone stock trades at Enfusion
Enfusion executives and stock owners
Enfusion executives and other stock owners filed with the SEC include:
-
Bronwen Bastone,
Chief People Officer -
Lorelei M. Skillman,
Chief Marketing Officer -
Brian Murphy,
Investor -
Daniel Groman,
MD & CTO -
Alan Polo,
Head of Account Management -
Michael Berry,
Chief Operating Officer -
Stephen P. Dorton,
Chief Financial Officer -
Stephen Malherbe,
Managing Partner -
Thomas Kim,
Chief Exec. Officer -
Tarek Hammoud,
Co-Founder & Exec. Chairman -
Steven M. Bachert,
Chief Revenue Officer -
Bradley Herring,
Chief Financial Officer -
Michael Spellacy,
Director -
Deirdre Somers,
Director -
Matthew Campobasso,
General Counsel -
Neal Pawar,
Chief Operating Officer -
Stephen Malherbe Investment...,
-
Lawrence E Leibowitz,
Director -
Bradford Eftv Iv, L.P. Bern...,
-
Oleg Movchan,
Director -
Oleg Csl Tech Holdings Llc ...,
Chief Executive Officer -
Investment Management, Ltd....,
10% owner -
Tarek Hammoud,
Director -
Strategic Partners V, L.P.I...,
-
Roy Luo,
Director -
Jan Hauser,
Director -
Kathleen De Rose,
Director -
Thomas Kim,
Chief Executive Officer -
Lorelei M. Skillman,
Chief Mrktg. & Comm. Officer -
Stephen M Dorton,
Chief Financial Officer -
Bronwen Bastone,
Chief People Officer -
Dan Groman,
Chief Technology Officer -
Tarek Lra Ventures, Llc Ham...,
-
Oleg Quiet Light Securities...,
Chief Executive Officer -
Valeria Gutowski,
Chief Accounting Officer